The Response of Human B Lymphocytes to Oligodeoxynucleotides

Overview

Journal Springer Semin Immunopathol

Specialty Allergy & Immunology

Date 2000 Aug 17

PMID 10944801

Citations 1

Authors

H Liang

P E Lipsky

Affiliations

Soon will be listed here.

Citing Articles

DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide.

Shoda L, Kegerreis K, Suarez C, Roditi I, Corral R, Bertot G Infect Immun. 2001; 69(4):2162-71.

PMID: 11254571 PMC: 98143. DOI: 10.1128/IAI.69.4.2162-2171.2001.

References

Pisetsky D . Immune activation by bacterial DNA: a new genetic code. Immunity. 1996; 5(4):303-10. DOI: 10.1016/s1074-7613(00)80256-3. View

Goodman J, Van Uden J, Kobayashi H, Broide D, Raz E . DNA immunotherapeutics: new potential treatment modalities for allergic disease. Int Arch Allergy Immunol. 1998; 116(3):177-87. DOI: 10.1159/000023943. View

Tokunaga T, Yamamoto H, Shimada S, Abe H, Fukuda T, Fujisawa Y . Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst. 1984; 72(4):955-62. View

Krieg A . An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J Lab Clin Med. 1996; 128(2):128-33. DOI: 10.1016/s0022-2143(96)90004-9. View

Liang H, Nishioka Y, Reich C, Pisetsky D, Lipsky P . Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest. 1996; 98(5):1119-29. PMC: 507533. DOI: 10.1172/JCI118894. View

Klinman D, Yamshchikov G, Ishigatsubo Y . Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol. 1997; 158(8):3635-9. View

Yi A, Klinman D, Martin T, Matson S, Krieg A . Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol. 1996; 157(12):5394-402. View

Shimada S, Yano O, Tokunaga T . In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG. Jpn J Cancer Res. 1986; 77(8):808-16. View

Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T . Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. J Immunol. 1992; 148(12):4072-6. View

10.

Sparwasser T, Koch E, Vabulas R, Heeg K, Lipford G, Ellwart J . Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol. 1998; 28(6):2045-54. DOI: 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8. View

11.

Yi A, Krieg A . CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. J Immunol. 1998; 160(3):1240-5. View

12.

Lipford G, Bauer M, Blank C, Reiter R, Wagner H, Heeg K . CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol. 1997; 27(9):2340-4. DOI: 10.1002/eji.1830270931. View

13.

Carson D, Raz E . Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination. J Exp Med. 1997; 186(10):1621-2. PMC: 2199144. DOI: 10.1084/jem.186.10.1621. View

14.

Chu R, Targoni O, Krieg A, Lehmann P, Harding C . CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med. 1997; 186(10):1623-31. PMC: 2199137. DOI: 10.1084/jem.186.10.1623. View

15.

Sparwasser T, Miethke T, Lipford G, Erdmann A, Hacker H, Heeg K . Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol. 1997; 27(7):1671-9. DOI: 10.1002/eji.1830270712. View

16.

Broide D, Schwarze J, Tighe H, Gifford T, Nguyen M, Malek S . Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol. 1998; 161(12):7054-62. View

17.

Fredriksen K, SKOGSHOLM A, Flaegstad T, Traavik T, Rekvig O . Antibodies to dsDNA are produced during primary BK virus infection in man, indicating that anti-dsDNA antibodies may be related to virus replication in vivo. Scand J Immunol. 1993; 38(4):401-6. DOI: 10.1111/j.1365-3083.1993.tb01744.x. View

18.

Zimmermann S, Egeter O, Hausmann S, Lipford G, Rocken M, Wagner H . CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol. 1998; 160(8):3627-30. View

19.

Yi A, Chang M, Peckham D, Krieg A, Ashman R . CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol. 1998; 160(12):5898-906. View

20.

Monteith D, Henry S, Howard R, Flournoy S, Levin A, Bennett C . Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Des. 1997; 12(5):421-32. View